ZA200200280B - Mycophenolate mofetil in association with PEG-IFN-alpha. - Google Patents

Mycophenolate mofetil in association with PEG-IFN-alpha.

Info

Publication number
ZA200200280B
ZA200200280B ZA200200280A ZA200200280A ZA200200280B ZA 200200280 B ZA200200280 B ZA 200200280B ZA 200200280 A ZA200200280 A ZA 200200280A ZA 200200280 A ZA200200280 A ZA 200200280A ZA 200200280 B ZA200200280 B ZA 200200280B
Authority
ZA
South Africa
Prior art keywords
ifn
peg
alpha
association
mycophenolate mofetil
Prior art date
Application number
ZA200200280A
Other languages
English (en)
Inventor
Mary Catherine Graves
Friederike Zahm
Stephen Chris Pappas
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA200200280B publication Critical patent/ZA200200280B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200200280A 1999-08-13 2002-01-11 Mycophenolate mofetil in association with PEG-IFN-alpha. ZA200200280B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99115950 1999-08-13

Publications (1)

Publication Number Publication Date
ZA200200280B true ZA200200280B (en) 2003-04-11

Family

ID=29762814

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200200280A ZA200200280B (en) 1999-08-13 2002-01-11 Mycophenolate mofetil in association with PEG-IFN-alpha.

Country Status (14)

Country Link
EP (1) EP1220683A2 (fr)
JP (1) JP2003507339A (fr)
CN (1) CN1368887A (fr)
AU (1) AU7408200A (fr)
BR (1) BR0013252A (fr)
CA (1) CA2380653A1 (fr)
HU (1) HUP0202525A3 (fr)
MX (1) MXPA02001296A (fr)
PE (1) PE20010490A1 (fr)
PL (1) PL357367A1 (fr)
RU (1) RU2002105485A (fr)
TR (1) TR200200401T2 (fr)
WO (1) WO2001012214A2 (fr)
ZA (1) ZA200200280B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307553D0 (en) * 2003-04-01 2003-05-07 Novartis Ag Organic compounds
DE602005013922D1 (de) 2004-02-24 2009-05-28 Japan Tobacco Inc Kondensierte heterotetracyclische verbindungen und deren verwendung als hcv-polymerase-inhibitor
US20070049593A1 (en) 2004-02-24 2007-03-01 Japan Tobacco Inc. Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
KR20070045244A (ko) * 2004-08-12 2007-05-02 쉐링 코포레이션 안정한 페길화된 인터페론 제형
US7659263B2 (en) 2004-11-12 2010-02-09 Japan Tobacco Inc. Thienopyrrole compound and use thereof as HCV polymerase inhibitor
US8017612B2 (en) 2006-04-18 2011-09-13 Japan Tobacco Inc. Piperazine compound and use thereof as a HCV polymerase inhibitor
WO2010110503A1 (fr) * 2009-03-27 2010-09-30 주식회사 중외제약 Protéine fusionnée d'interféron-α (ifn-α) comprenant l'ifn-α et un peptide de transduction cytoplasmique (ctp)
US8466159B2 (en) 2011-10-21 2013-06-18 Abbvie Inc. Methods for treating HCV
CH707029B1 (de) 2011-10-21 2015-03-13 Abbvie Inc Verfahren zur Behandlung von HCV, umfassend mindestens zwei direkt wirkende antivirale Wirkstoffe, Ribavirin, aber nicht Interferon.
US8492386B2 (en) 2011-10-21 2013-07-23 Abbvie Inc. Methods for treating HCV
EP2583680A3 (fr) 2011-10-21 2013-06-12 Abbvie Inc. Traitement seul (PSI-7977) ou combinatoire dans l'utilisation pour le traitement du VHC
EP3215193B1 (fr) * 2014-11-06 2023-10-04 PharmaEssentia Corporation Régime posologique pour l'interféron pégylé
EA201892448A1 (ru) 2016-04-28 2019-06-28 Эмори Юниверсити Алкинсодержащие нуклеотидные и нуклеозидные терапевтические композиции и связанные с ними способы применения

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5908621A (en) * 1995-11-02 1999-06-01 Schering Corporation Polyethylene glycol modified interferon therapy
MY125300A (en) * 1999-02-26 2006-07-31 Inst Of Molecular And Cell Biology Synergistic combination for treatment of viral-mediated diseases

Also Published As

Publication number Publication date
WO2001012214A2 (fr) 2001-02-22
JP2003507339A (ja) 2003-02-25
HUP0202525A2 (hu) 2002-11-28
BR0013252A (pt) 2002-04-16
CA2380653A1 (fr) 2001-02-22
CN1368887A (zh) 2002-09-11
WO2001012214A3 (fr) 2001-10-04
AU7408200A (en) 2001-03-13
PE20010490A1 (es) 2001-04-27
TR200200401T2 (tr) 2002-06-21
HUP0202525A3 (en) 2003-11-28
MXPA02001296A (es) 2002-07-22
EP1220683A2 (fr) 2002-07-10
RU2002105485A (ru) 2004-01-27
PL357367A1 (en) 2004-07-26

Similar Documents

Publication Publication Date Title
ZA200107409B (en) Fuel composition.
GB2349180B (en) Inverted I.C.engine configuration
HK1069913A1 (en) Generalized text localization in images.
MXPA01013362A (es) Anticuerpos de humano, anti-alfavbeta3 recombinantes, °cidos nucleicos que codifican a los mismos y metodos de uso.
EG24361A (en) 4-pyrimiding1-n-acy1.l.phenlalanines
ZA200200477B (en) 2-pyrazolin-5-ones.
ZA200202537B (en) Pour-on-formulations.
ZA200203762B (en) 4-pyridinyl-IN-acyl-L-phenylalanines.
MXPA02002209A (es) Recipiente con mensaje.
ZA200110395B (en) Catalytic cellulignin fuel.
ZA200200280B (en) Mycophenolate mofetil in association with PEG-IFN-alpha.
ITRE990028A0 (it) Integratore alimentare chelato ad uso agro-zootecnico, e metodo per l' ottenimento dello stesso.
HK1032814A1 (en) Absorber.
ITTO990892A0 (it) Macchina per caffe'.
IL147612A0 (en) MYCOPHENOLATE MOFETIL IN ASSOCIATION WITH PREG-IFN-α
ZA200005803B (en) Personal Watercraft Engine.
ZA992018B (en) Banners.
MXPA03003525A (es) Concentrador de enlace posterior de enrutamiento escalable.
Jakubczak Sankhja i joga. Podstawy filozofii Patańdżalego
Lysenko et al. Maliariologiia
Tucker Santamarian 1999
Bhoje Shivaji Vidyapith sallgnit B ed mahavidyalyatil pratyakshik karyachya karyvahit yenarya samsyancha abhyas
Larsson-Kråik Fullskalig testrigg: förstudie
Starčević et al. Milanković juče danas sutra
Funder Deconstructing Philosophy